March 10, 2020 / 9:12 PM / a month ago

BRIEF-Biovica Says Intends To Submit An FDA Application For Market Approval Of Divitum In Q3 Of 2020

March 10 (Reuters) - Biovica International AB:

* BIOVICA PROVIDES UPDATES ON FDA APPLICATION

* BIOVICA INTERNATIONAL - INTENDS TO SUBMIT AN FDA APPLICATION FOR MARKET APPROVAL OF DIVITUM IN Q3 OF 2020 AND NOT AS PREVIOUSLY ANNOUNCED IN MID-2020

* BIOVICA INTERNATIONAL AB - DUE TO DELIVERY DELAYS OF A COMPONENT THAT IS PART OF DIVITUM, PRODUCTION HAS BEEN DELAYED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below